Threes Company: Regulation of Cell Fate by Statins
Journal:
Current Drug Targets - Cardiovascular & Hematological Disorders
Volume:
5
Page:
145-163
Author(s):
Joannis E. Vamvakopoulos
Analysis of the Potential for HIV-1 Vpr as an Anti-Cancer Agent
Journal:
Current HIV Research
Volume:
7
Page:
144-152
Author(s):
Karrupiah Muthumani, Vance M. Lambert, Niranjan Y. Sardesai, Jong J. Kim, Richard Heller, David B. Weiner and Kenneth E. Ugen
Recent Therapeutic Advances for Treating Medulloblastoma: Focus on New Molecular Targets
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
9
Page:
335-348
Author(s):
A.L. Schmidt, A.L. Brunetto, G. Schwartsmann, R. Roesler and A.L. Abujamra
Human Apurinic/Apyrimidinic Endonuclease (APE1): An Emerging Anti-Cancer Biomarker
Journal:
Recent Patents on Biomarkers
Volume:
1
Page:
150-158
Author(s):
Raghav Murali-Ganesh, Rishi Malhotra, Christina J. Perry and Srinivasan Madhusudan
Nasal Polyposis: An Overview of Differential Diagnosis and Treatment
Journal:
Recent Patents on Inflammation & Allergy Drug Discovery
Volume:
5
Page:
241-252
Author(s):
Cemal Cingi, Duygu Demirbas and Ahmet Ural
APE1/Ref-1Role in Redox Signaling: Translational Applications of Targeting the Redox Function of the DNA Repair/Redox Protein APE1/Ref-1
Journal:
Current Molecular Pharmacology
Volume:
5
Page:
36-53
Author(s):
Mark R. Kelley, Millie M. Georgiadis and Melissa L. Fishel